Kura Oncology Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	95.29	224.46	37.32	51.8	90.67	325.49
Short-Term Investments	454.38	502.93	386.64	386.18	427.29	307.83
Cash & Short-Term Investments	549.67	727.4	423.96	437.99	517.96	633.32
Cash Growth	20.73%	71.57%	-3.20%	-15.44%	-18.21%	167.35%
Accounts Receivable	35.94	2.06	-	-	-	-
Other Current Assets	35.06	15.37	8.52	8.44	4.33	3.97
Total Current Assets	620.66	744.83	432.48	446.43	522.29	637.29
Net Property, Plant & Equipment	14.94	7.49	8.68	6.38	8.25	8.36
Other Long-Term Assets	13.78	7.85	7.6	3.5	3.52	1.57
Total Assets	649.38	760.16	448.94	456.31	534.05	647.21
Accounts Payable	66.79	49.95	33.76	21.74	20.19	23.02
Current Portion of Long-Term Debt	4.34	2.61	-	-	-	3
Current Portion of Leases	1.43	1.88	1.51	2.32	2.26	-
Unearned Revenue	48.75	24.27	-	-	-	-
Total Current Liabilities	121.3	78.71	35.26	24.06	22.46	26.02
Long-Term Debt	5.34	6.92	9.33	9.16	-	4.25
Long-Term Leases	8.36	5.19	6.36	2.55	4.61	5.64
Other Long-Term Liabilities	271.84	255.7	0.71	0.27	0.38	0.4
Total Long-Term Liabilities	285.54	267.81	16.4	11.97	4.99	10.28
Total Liabilities	406.84	346.52	51.66	36.03	27.44	36.31
Common Stock	0.01	0.01	0.01	0.01	0.01	0.01
Additional Paid-in Capital	1,335	1,308	1,120	997.11	941.36	913.35
Accumulated Other Comprehensive Income	0.92	0.76	-1.27	-8.03	-1.79	0.05
Retained Earnings	-1,093	-895.42	-721.44	-568.81	-432.97	-302.5
Shareholders' Equity	242.54	413.64	397.27	420.28	506.61	610.91
Total Liabilities & Equity	649.38	760.16	448.94	456.31	534.05	647.21
Total Debt	19.47	16.59	17.2	14.02	6.88	12.89
Net Cash (Debt)	530.2	710.8	406.76	423.96	511.09	620.43
Net Cash Growth	-25.41%	74.75%	-4.06%	-17.05%	-17.62%	170.47%
Net Cash Per Share	6.06	8.25	5.55	6.33	7.70	11.69
Book Value	242.54	413.64	397.27	420.28	506.61	610.91
Book Value Per Share	2.77	4.80	5.43	6.27	7.64	11.51
Tangible Book Value	242.54	413.64	397.27	420.28	506.61	610.91
Tangible Book Value Per Share	2.77	4.80	5.43	6.27	7.64	11.51

Updated Nov 4, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q